greeksoup/ stock research
Stock research / United States / TWST / Filings

Twist Bioscience Corp. SEC filings

Twist Bioscience filed 18 documents with the SEC in the last twelve months, the latest report being the 10-Q of 3 August 2026. The latest filing, on 19 August 2026, was an 8-K: regulation fd disclosure.

Filings in twelve months1810 of them 8-K news
Latest report10-Qfiled 3 Aug 2026
Latest filing8-K19 Aug 2026
Last results, two-day move+8.6%results filed 3 Aug 2026
New to this? How to read this page
  1. Companies file with the SEC when something happens. 10-Q and 10-K are the quarterly and annual reports; 8-K is news that cannot wait for the next report.
  2. An 8-K says which items it covers, such as results, a change at the top or a big contract. A foreign company files a 6-K instead.
  3. The results release is usually an 8-K filed the day results come out, before the 10-Q or 10-K.
  4. Every filing links to the original on EDGAR, the SEC's own site.

Twelve months of filings

by kind

Most of the filings were results (5). Results came out 5 times.

Each mark is one filing on the day it was filed, in rows by kind. Hover or tap a mark for the form and what it was about.

The share price around each results release

close before to close after

Over the last 5 releases the share price moved 10.6% on average in the two days around results, the most on 12 Jan 2026 (+13.9%).

12 Jan 2026+13.9%$35.32 to $40.22
2 Feb 2026+12.8%$41.07 to $46.32
4 May 2026-6.1%$60.40 to $56.70
3 Aug 2026+8.6%$91.55 to $99.44
Daily closeResults filed

Each ring marks a results filing. The move runs from the last close before the filing to the first close after it, so it covers results released before the open or after the close. Hover the line for any day's close.

What the company told investors on 8-K

10 filings

Twist Bioscience's 10 news filings (8-K) were mostly about results of operations (5) and regulation FD disclosure (2).

  • Results of operationsThe quarterly results release
    5 · latest 3 Aug 2026
  • Regulation FD disclosureMaterial shared with investors, often slides or a presentation
    2 · latest 19 Aug 2026
  • Other eventsNews the company chose to file
    2 · latest 19 Aug 2026
  • Material agreementA large contract or deal was signed
    1 · latest 5 Aug 2026
  • Unregistered sale of equityShares sold privately
    1 · latest 17 Feb 2026
  • Shareholder voteResults of a vote at a shareholder meeting
    1 · latest 6 Feb 2026

Each line is one kind of news, with what it means in plain words. Each square is one filing; a filing can carry more than one kind, so the squares can add up to more than the filings. The date opens the latest one on EDGAR.

How it compares

every company on the site

    The bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.

    Every filing as a table

    In the last twelve months Twist Bioscience Corp. filed 18 documents with the SEC of the kinds listed here: 10 current reports (8-K), about 5 results of operations; 2 regulation FD disclosure; 2 other events; 1 material agreement; 1 unregistered sale of equity; 3 quarterly reports (10-Q), 1 shelf registration (S-3ASR), 1 amended quarterly report (10-Q/A), 1 annual report to shareholders (ARS), 1 proxy statement (DEF 14A), 1 annual report (10-K). The latest, filed 19 August 2026: 8-K, regulation FD disclosure. The 10-K, the 10-Qs and the proxy statement themselves, each with a link to open it, are on the documents page.

    FiledFormWhat it was aboutPeriod or event dateFiling
    19 August 20268-KRegulation FD disclosure18 August 2026EDGAR
    19 August 20268-KOther events19 August 2026EDGAR
    5 August 20268-KMaterial agreement, Regulation FD disclosure4 August 2026EDGAR
    3 August 202610-Qquarterly report30 June 2026EDGAR
    3 August 20268-KResults of operations3 August 2026EDGAR
    18 June 2026S-3ASRshelf registrationEDGAR
    4 May 202610-Qquarterly report31 March 2026EDGAR
    4 May 20268-KResults of operations4 May 2026EDGAR
    26 February 202610-Q/Aamended quarterly report31 December 2025EDGAR
    17 February 20268-KUnregistered sale of equity, Other events11 February 2026EDGAR
    6 February 20268-KShareholder vote5 February 2026EDGAR
    2 February 202610-Qquarterly report31 December 2025EDGAR
    2 February 20268-KResults of operations2 February 2026EDGAR
    12 January 20268-KResults of operations12 January 2026EDGAR
    6 January 2026ARSannual report to shareholders30 September 2025EDGAR
    6 January 2026DEF 14Aproxy statement5 February 2026EDGAR
    17 November 202510-Kannual report30 September 2025EDGAR
    14 November 20258-KResults of operations14 November 2025EDGAR
    An 8-K is what a company files within four business days of a material event; the SEC numbers the events, and the words here are the SEC's own headings, shortened.
    Read moreForm 4, Form 144, 13F and Schedule 13D and 13G have their own pages. Prospectus supplements and correspondence are not listed.